Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Shares Slump Following Resignation of Board Chairman

NEW YORK (GenomeWeb News) – Transgenomic shares were down nearly 9 percent in mid-afternoon trading today following the company’s announcement this morning that the chairman of its board of directors, Collin D’Silva, had resigned.
 
Transgenomic shares reached a low of $.65 during the day, down 9.7 percent from their previous close of $.72.
 
D’Silva was a co-founder of Transgenomic and served as president and CEO from 1998 to 2006.
 
D’Silva has also resigned from his position as secretary of the company, though he will remain as director of mergers and acquisitions until at least March 31.
 
Transgenomic board member Gregory Sloma will serve as chairman on an interim basis until a new chairman is appointed. In addition, Craig Tuttle, the company’s current president and CEO, has been elected to the board to fill the vacancy created by D'Silva's resignation, and CFO Debra Schneider has been appointed secretary.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.